drugset / Trial / NCT01087359

Antiinflammatoric and Antioxidative Effect of Melatonin in Human Endotoxaemia

NCT01087359

Phase 4 Completed 12 enrolled Herlev Hospital
RandomizedCrossoverDouble-blindPrevention

Summary

This is a double blinded, randomised, crossover study with 12 healthy men between 18 and 40 year. The design is based on 6 days: * day 1: On day time administration of LPS. * day 2: On night time administration of LPS. * day 3: On day time administration of LPS + Placebo. * day 4: On day time administration of LPS + melatonin. * day 5: On night time administration of LPS + placebo. * day 6: On night time administration og LPS + melatonin. Measuring the inflammatoric and oxidative response of LPS and the effect of melatonin compared to placebo on the endotoxaemia.

Timeline

Start
2010-06
Primary completion
2011-01
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 100 mg

Indications

No indication recorded.